ROCKVILLE, Md. - Emergent BioSolutions Inc. said it has received approval to sell its Lansing-made anthrax vaccine in India.
Emergent said Biological E. Limited will market the BioThrax vaccine in India.
BioThrax is the only anthrax vaccine approved by the U.S. Food and Drug Administration.
An Indian government authority that oversees disaster management issued a report in 2008 calling for that country to have a supply of anthrax vaccine, Emergent said.
Emergent makes the BioThrax vaccine at its north Lansing campus, which employs about 350 workers.
It's primary customer for the anthrax vaccine has been the U.S. government.
Aggarwal's Blog
India clears Emergent for anthrax vaccine sales
Author
Advertisement
Popular Posts
- Top medical colleges in India (2008)
- Top-selling mouthwash brands linked to oral cancer
- Medical College Ratings
- India's first emergency medical services launched by Rapid Rescue Services
- Pharma cos agree to code on freebies
- Guided radiation to target cancer cells on the move
- Patients satisfied with wired docs
- Mehta abortion case
- Rural posting compulsory for doctors in India
- AIIMS - wonder surgery for Supratim
Loading recent content...
Post Comments
Add Your Comment!
Log in to leave a comment or Create an account
» All comments» Comments RSS